Meeta Cardon
Neurology with Special Qualifications in Child Neurology · Albuquerque, NMNPI 1366737256
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,580 of the $18,626 with a category attached, or 67.5%. Sarepta Therapeutics, Inc. accounts for 85.8% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $10,196, more than ten times the $816 reported in 2019.
Across 90 payments — averaging $206.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sarepta Therapeutics, Inc.$16K
- Catalyst Pharmaceuticals, Inc.$1K
- Biogen$238
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$168
- Novartis$137
- PTC Therapeutics, Inc.$127
- plus $655 from 20 others
Across 4 payments — averaging $2003.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$8K
What the payments were for
- Consulting fees$12,58068%
- Speaking & faculty fees$1,2006%
- Travel & lodging$2,72315%
- Food & beverage$2,12311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sarepta Therapeutics, Inc. | 27 | $15,975 |
| Catalyst Pharmaceuticals, Inc. | 2 | $1,325 |
| Biogen | 7 | $238 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 4 | $168 |
| Novartis | 1 | $137 |
| PTC Therapeutics, Inc. | 6 | $127 |
| Greenwich Biosciences, Inc. | 7 | $112 |
| Aquestive Therapeutics, Inc. | 6 | $86 |
| UCB, Inc. | 4 | $65 |
| Neos Therapeutics, LP | 4 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Ironshore Pharmaceuticals Inc. | 2 | $29 |
| Sanofi | 2 | $27 |
| Saol Therapeutics Inc. | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Tris Pharma Inc | 2 | $24 |
| Upsher-smith Laboratories LLC | 1 | $24 |
| Vertical Pharmaceuticals, LLC | 2 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
| SK Life Science, Inc. | 1 | $14 |
| Neurelis, Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $11 |
| Eisai Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neurology with special qualifications in child neurology providers in New Mexicoto place this figure against a meaningful peer group, so we don't.
Other neurology with special qualifications in child neurology in Albuquerque
- Leslie MorrisonAlbuquerque$13K
- Aaron CardonAlbuquerque$3K
- Abby KunzAlbuquerque$861
- Harsheen KaurAlbuquerque$833
- Jennifer VickersAlbuquerque$178
- Nicola RossAlbuquerque$123
- John MasonAlbuquerque$100
- Kathy WolfeAlbuquerque$100
- Mary JohnsonAlbuquerque$80
- Russell SnyderAlbuquerque$24
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.